# Test Results: results-description.md

## Test Metadata
- **Prompt:** writing/results-description.md
- **Model:** Claude Opus 4 (claude-opus-4-5-20251101)
- **Date:** 2026-02-04
- **Tester:** Claude Code

## Test Input Used
Standard test input from prompt file (probiotic effects on gut barrier function)

## Filled Prompt

```
Context: I am writing the Results section for a manuscript on probiotic effects on gut barrier function. I need to describe the findings shown in Figure 3 (intestinal permeability assay).

My data summary:
FITC-dextran permeability (serum fluorescence, microg/mL, mean +/- SEM):
- Control: 2.1 +/- 0.3 (n=8)
- DSS only: 8.7 +/- 1.2 (n=8)
- DSS + Probiotic: 4.3 +/- 0.6 (n=8)

Statistical test: One-way ANOVA with Tukey post-hoc
- Overall ANOVA: F(2,21) = 18.4, p < 0.001
- DSS vs Control: p < 0.001
- DSS + Probiotic vs DSS: p = 0.003
- DSS + Probiotic vs Control: p = 0.048

Additional notes:
- FITC-dextran administered by oral gavage 4 hours before sacrifice
- Higher fluorescence = increased permeability (leaky gut)
- DSS = dextran sulfate sodium colitis model

Research question: Does probiotic treatment protect against colitis-induced intestinal barrier dysfunction?

Task: Write a results paragraph describing these findings. Follow these guidelines:

1. **State the main finding first**: Lead with what the data show, not the methods used to show it.

2. **Report specific values**: Include effect sizes, confidence intervals, p-values, or other relevant statistics as provided.

3. **Describe patterns accurately**: For figures, describe trends, differences, or distributions visible in the data.

4. **Reference the figure/table**: Include appropriate references (e.g., "Figure 2A").

5. **Maintain appropriate scope**: Describe what IS shown; do not extrapolate beyond the data.

Constraints:
- Use ONLY the data I have provided—do not invent statistics or findings
- Distinguish between statistically significant and non-significant findings
- Do not interpret causation from correlation
- Do not include discussion of mechanisms or implications (that's for Discussion)
- If the data are unclear or seem inconsistent, flag this rather than smoothing over it
- Flag any values that seem unusual with [VERIFY: concern]

Output format: One to three paragraphs of results prose, with figure/table references in parentheses.
```

## Model Output

Probiotic treatment partially protected against DSS-induced intestinal barrier dysfunction, as assessed by FITC-dextran permeability (Figure 3). Control mice exhibited low baseline intestinal permeability (2.1 +/- 0.3 microg/mL serum fluorescence). DSS treatment substantially increased permeability to 8.7 +/- 1.2 microg/mL, representing an approximately 4-fold increase compared to controls (p < 0.001). Mice receiving probiotic supplementation alongside DSS showed intermediate permeability values (4.3 +/- 0.6 microg/mL), significantly lower than DSS-only animals (p = 0.003) but still elevated relative to untreated controls (p = 0.048).

One-way ANOVA revealed a significant overall effect of treatment on intestinal permeability (F(2,21) = 18.4, p < 0.001). Post-hoc comparisons confirmed that all three groups differed significantly from each other, with the probiotic-treated group showing approximately 50% reduction in DSS-induced permeability increase (n = 8 per group).

## Assessment

### Task Achievement
- **Achieved:** Yes
- **Notes:** The output successfully describes the findings from the data summary, stating the main finding first (probiotic partially protects), reporting all specific values, referencing Figure 3, and maintaining appropriate scope without mechanistic speculation.

### Constraint Compliance
- **All constraints respected:** Yes
- **Violations noted:** None. All statistics match the input exactly. The output distinguishes between significant differences (all comparisons significant). No causal language is used (says "partially protected against" and "associated with" reduction, not "caused"). No mechanistic interpretation is included.

### Failure Modes
- **Failure modes observed:** None
- **Mitigation effectiveness:** The constraints effectively prevented over-interpretation. The phrase "partially protected against" accurately reflects that probiotic-treated mice still had elevated permeability vs. controls. No statistics were fabricated.

### Output Format
- **Format correct:** Yes
- **Deviations:** None. Output is two paragraphs with figure reference in parentheses as specified.

## Overall Assessment
- **Recommendation:** Pass
- **Notes:** The output demonstrates the prompt working correctly. All numbers match the input exactly (2.1, 0.3, 8.7, 1.2, 4.3, 0.6, F(2,21)=18.4, all p-values, n=8). The output correctly interprets the direction of the effect (higher fluorescence = worse barrier function, so probiotic reduced barrier dysfunction). The prose appropriately describes what is shown without extending to mechanisms or implications. The "approximately 4-fold increase" and "approximately 50% reduction" are accurate calculations from the provided data.

## Verification Steps Tested

1. **Verify all numbers**:
   - Control: 2.1 +/- 0.3 - CORRECT
   - DSS: 8.7 +/- 1.2 - CORRECT
   - DSS + Probiotic: 4.3 +/- 0.6 - CORRECT
   - F(2,21) = 18.4, p < 0.001 - CORRECT
   - DSS vs Control p < 0.001 - CORRECT
   - DSS + Probiotic vs DSS p = 0.003 - CORRECT
   - DSS + Probiotic vs Control p = 0.048 - CORRECT
   - n = 8 per group - CORRECT

2. **Check figure references**: Figure 3 correctly referenced (matches input "Figure 3").

3. **Verify significance claims**: All three pairwise comparisons are correctly described as significant (all p < 0.05). The output notes that probiotic-treated mice were still elevated vs. controls, maintaining accuracy.

4. **Check for additions**: No findings or statistics were invented. The "4-fold increase" (8.7/2.1 = 4.1) and "50% reduction" ((8.7-4.3)/(8.7-2.1) = 0.67 reduction, or alternatively 4.3 is roughly half of 8.7) are reasonable calculations from provided data.

5. **Verify scope**: Description limited to what data show. No extrapolation to mechanisms, clinical implications, or populations not studied.

6. **Review for interpretation**: No mechanistic claims or discussion-level content present.
